> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Enhancing Diversity in Pediatric Drug Development Workshop
- URL: https://www.fdaweb.com/enhancing-diversity-in-pediatric-drug-development-workshop/
- Published: 2024-08-06T12:00:00.000Z
- Updated: 2026-09-14T14:37:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157508

*Federal Register* notice: FDA is announcing a 9/6 public workshop entitled “Enhancing Diversity in Therapeutics Development for Pediatric Patients” to discuss strategies to increase the enrollment of underrepresented populations in pediatric clinical trials and to help improve the strength and generalizability of the evidence for the intended use population. Specific topics to be covered include:

- The current state and challenges of pediatric clinical trial participation
- Metrics for assessing representative clinical study enrollment,
- Key elements of a strategy to include a more representative population, including trial design and methodological considerations, community engagement, recruitment and retention practices

To view the notice, click [here](https://public-inspection.federalregister.gov/2024-16365.pdf?ref=fdaweb.com).